nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials
|
Nozawa, Kazuki |
|
|
174 |
C |
p. |
artikel |
2 |
Clinical and technical challenges of cancer reirradiation: Words of wisdom
|
Beddok, Arnaud |
|
|
174 |
C |
p. |
artikel |
3 |
Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective
|
Hermans, Cedric |
|
|
174 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
174 |
C |
p. |
artikel |
5 |
Exercise oncology during and beyond the COVID-19 pandemic: Are virtually supervised exercise interventions a sustainable alternative?
|
Gonzalo-Encabo, Paola |
|
|
174 |
C |
p. |
artikel |
6 |
Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
|
Nocco, Sarah |
|
|
174 |
C |
p. |
artikel |
7 |
Immunotherapy for head and neck cancer: Present and future
|
Fasano, Morena |
|
|
174 |
C |
p. |
artikel |
8 |
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
|
Bhattacharjee, Rahul |
|
|
174 |
C |
p. |
artikel |
9 |
Nanomedicine tactics in cancer treatment: Challenge and hope
|
Al-Zoubi, Mazhar Salim |
|
|
174 |
C |
p. |
artikel |
10 |
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?
|
Audisio, Marco |
|
|
174 |
C |
p. |
artikel |
11 |
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era
|
Catania, Chiara |
|
|
174 |
C |
p. |
artikel |
12 |
Paraneoplastic syndromes review: The great forgotten ones
|
Sardiña González, Cristina |
|
|
174 |
C |
p. |
artikel |
13 |
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups
|
Perrucci, Elisabetta |
|
|
174 |
C |
p. |
artikel |
14 |
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management
|
Bellmunt, Joaquim |
|
|
174 |
C |
p. |
artikel |
15 |
Risk of thrombosis with thrombopoietin receptor agonists for ITP patients
|
Murphy, Philip |
|
|
174 |
C |
p. |
artikel |
16 |
SELNET clinical practice guidelines for bone sarcoma
|
Blay, JY |
|
|
174 |
C |
p. |
artikel |
17 |
The application of cancer stem cell model in malignant mesothelioma
|
Bronte, Giuseppe |
|
|
174 |
C |
p. |
artikel |
18 |
The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
|
Guven, Deniz Can |
|
|
174 |
C |
p. |
artikel |
19 |
The HER family as therapeutic targets in colorectal cancer
|
Ye, Peng |
|
|
174 |
C |
p. |
artikel |